Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rocket Doctor AI ( (TSE:AIDR) ) just unveiled an announcement.
Rocket Doctor AI Inc., a physician-led medical AI and digital health platform provider, has increased the size of its previously announced non-brokered private placement under the listed issuer financing exemption to a maximum of $5.2 million in gross proceeds, with units priced at $0.70, reflecting strong investor demand. The company has filed an amended and restated offering document on SEDAR+ and its own website to reflect the upsize, a move that is expected to bolster its capital position as it advances its AI-driven clinical decision-support tools and virtual care marketplace, potentially strengthening its competitive footing in technology-enabled healthcare and supporting expansion into underserved markets.
The most recent analyst rating on (TSE:AIDR) stock is a Hold with a C$0.78 price target. To see the full list of analyst forecasts on Rocket Doctor AI stock, see the TSE:AIDR Stock Forecast page.
Spark’s Take on TSE:AIDR Stock
According to Spark, TipRanks’ AI Analyst, TSE:AIDR is a Neutral.
The score is primarily held down by weak financial performance—minimal revenue scale, large operating losses, and sharply worsening cash burn—implying high execution and funding risk. Technicals are also soft (negative MACD and price below short/intermediate moving averages). Offsetting factors include a string of positive corporate developments (U.S. insurer access expansion, funding/grants, partnerships, and an announced acquisition), but valuation support is limited given negative earnings and no dividend yield provided.
To see Spark’s full report on TSE:AIDR stock, click here.
More about Rocket Doctor AI
Rocket Doctor AI Inc. is a Vancouver-based digital health and medical AI company that delivers physician-built, AI-powered solutions aimed at improving access to high-quality healthcare across the patient journey. Its core technology includes the Global Library of Medicine, a clinically validated decision-support system developed with input from hundreds of physicians globally, and the Rocket Doctor Inc. platform, an AI-enabled digital health marketplace that has supported over 300 physicians in delivering more than 700,000 virtual and hybrid patient visits. The company focuses on reducing administrative burden, enhancing consistency of care, and reaching underserved, rural, and remote communities in Canada as well as patients on Medicaid and Medicare in the United States, positioning itself as a player in scalable, equitable, patient-centered care.
YTD Price Performance: 8.22%
Average Trading Volume: 245,322
Technical Sentiment Signal: Buy
Current Market Cap: C$67.13M
For detailed information about AIDR stock, go to TipRanks’ Stock Analysis page.